08.24.26 -- STREAM: Small Molecules, Big Impact Across Drug Development

PMWC 2027: The program is live. Explore 15 focused programs spanning next-generation therapeutics, AI and computational medicine, precision diagnostics, and integrated precision medicine. Co-hosted by Stanford, UCSF, and Yale, PMWC features leaders including David Baker, Emmanuelle Charpentier, Andrew Ng, Fei-Fei Li, and Mary-Claire King, January 27-29, 2027, at the Santa Clara Convention Center.

Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

See how flexible single-use manufacturing strategies can accelerate scale-up, improve efficiency, and help streamline the journey from clinical development to commercialization.

Dr. Jordan Potts demonstrates how the Buchi B-290 spray dryer works and discusses its role in spray drying, particle engineering, and the development of optimized drug product formulations.

When component suppliers only own their part, system-level performance becomes your responsibility. And if something fails, accountability disappears into the gaps.

Combining targeted transposon tech with stable bulk pool generation accelerates cell line development, enabling early material production and fast-tracking candidate selection for clinical entry.

This segment of the Outsourced Pharma Live event, “Charting A Direct Pathway From Academia To CDMOs,” outlines the minimum information an academic or early-stage team should bring to its first serious CDMO discussion.